secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001171843-23-005387
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics grants 300,000 inducement options to new CEO; Nevin elected Chairman
--------------------------------------------------------------------------------

- Inducement options to purchase 300,000 shares granted to CEO Brian Hullinger at $4.65/share exercise price.
- Options vest in three tranches: 100,000 time-based over 2 years; 200,000 performance-based on stock price targets.
- Darius G. Nevin elected Chairman of the Board, succeeding Raymond C. Kubacki who retired on August 17, 2023.
- Annual meeting results: All six director nominees elected; advisory vote on exec compensation approved; BDO USA ratified as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/0001171843-23-005387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/f8k_082123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer